透過您的圖書館登入
IP:18.191.236.174
  • 學位論文

KMUP-1和KMUP-3在大鼠氣管平滑肌細胞對抗SIPHGOSINE-1-PHOSPHATE(S1P)和U46619誘發有關RHO KINASE和PROTEIN KINASE C的蛋白質表現

KMUP-1 and KMUP-3 inhibit Siphgosine-1- phosphate (S1P) and U46619-induced Rho Kinase and Protein Kinase C in rat tracheal smooth muscle cells.

指導教授 : 陳英俊
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


在氣管平滑肌收縮路徑中,G 蛋白調解的鈣離子敏感性牽涉了Rho kinase(ROK)與Protein Kinase C(PKC)兩條路徑。Sphingosine-1-phosphate(S1P)與U46619兩種刺激劑皆可活化ROK 與PKC的表現。而S1P屬於神經鞘酯類(sphingolipid)代謝物,U46619是thromboxane A2 衍生物,兩者皆會引起氣管平滑肌收縮。本實驗室已經證明KMUP-1與KMUP-3在不同濃度(1-100 μM)可使收縮的氣管產生放鬆,本研究則深入探討其涉入的機轉。而由結果顯示,除了S1P所誘導PKCα較無明顯抑制趨勢,KMUP-1與KMUP-3(0.1-100 μM)皆可明顯抑制由S1P(2 μM)或U46619(1 μM)誘發的ROKα及PKCα表現,且呈現劑量相關性。 除此之外,本研究中以KMUP-1、KMUP-3、Y27632(Rho kinase抑制劑)、Dexamethasone、Terbutaline、Chelerythrine chloride(Protein kinase C抑制劑)、8-bromo-cGMP與8-bromo-cAMP(10 μM),來比較對於PKCα及ROKα抑制能力。數據顯示除了S1P所誘導PKCα較無明顯抑制趨勢(數據未提供),而相較於Dexamethasone與Terbutaline,KMUP-1與KMUP-3皆可發揮較佳的抑制效果,且KMUP-1的抑制效果亦與Y27632、Chelerythrine chloride相近。 另外,細胞內鈣離子濃度實驗中亦發現,由S1P刺激後增加的細胞內鈣離子濃度皆會被KMUP-1所抑制,但KMUP-3對於細胞內鈣離子濃度較無明顯抑制趨勢。 由於KMUP-1和KMUP-3可以藉由抑制氣管平滑肌細胞的ROK、 PKC 蛋白質表現及降低細胞內鈣離子濃度,而達到抑制由鈣離子依賴性及鈣離子敏感性所導致的收縮現象。透過各項實驗結果,針對KMUP-1與KMUP-3的效能,可提供臨床上另一種治療氣喘的新方法。

並列摘要


G protein-mediated Ca2+ sensitization in contraction of tracheal smooth muscle(TSM)is involved in Rho kinase (ROK)and Protein Kinase C(PKC)activation pathways. The expression of ROK and PKC are activated by Sphingosine-1-phosphate (S1P)and U46619. S1P, a bioactive sphingolipid metabolite, and U46619, a thromboxane A2 analogue, both can induce TSM contractions. Our laboratory has demonstrated that KMUP-1 and KMUP-3(1-100 μM)relax the contraction of rat TSM. The results indicated that the expression of ROK and PKCα induced by S1P(2 μM)or U46619(1 μM)in cultured TSM cells were dose-dependently inhibited by KMUP-1 and KMUP-3(0.1 - 100 μM), analyzed by western blotting, except the expression of PKCα induced by S1P(2 μM). After further investigation for the discrepancy between KMUP-1, KMUP-3, Y27632, Chelerythrine chloride, Dexamethasone, Terbutaline, 8-bromo-cGMP and 8-bromo-cAMP(10 μM), KMUP-1 and KMUP-3 possess similar inhibition activities on the expression of ROKα and PKCα proteins as Y27632 and Chelerythrine chloride. Relative to 10μM Dexamethasone and 10μM Terbutaline, both of 10μM KMUP-1 and 10μM KMUP-3 have batter inhibitions on the expression of ROKα and PKCα protein。 In addition, the intracellular concentration of Ca2+ induced by S1P was significantly decreased by KMUP-1. However, KMUP-3 has slight inhibition on the intracellular concentration of Ca2+。 From the results, in this study, it is proposed that KMUP-1 could inhibit the contraction of airway smooth muscle by mediating the intracellular concentration of Ca2+。Those new medicines, KMUP-1 and KMUP-3, developed by our laboratory, could possess well capabilities to inhibit the contraction induced by mechanisms of Ca2+ dependent and Ca2+ sensitization due to dose-dependently inhibitions of PKCα, ROKα and intracellular concentration of Ca2+. In conclusion, KMUP-1 and KMUP-3 may indicate the batter clinical application in the treatment of asthma.

參考文獻


1.Allen IC, Hartney JM, Coffman TM, Penn RB, Wess J, Koller BH (2006). Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism .Am J Physiol Lung Cell Mol Physiol. Mar; 290(3): L526-33.
2.Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, Kane SA, Peters SP, Penn RB, Spiegel S, Panettieri RA Jr (2001). Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. May; 15(7): 1212-4.
3.Amrani Y, Panettieri RA (2003). Airway smooth muscle: contraction and beyond. Int J Biochem Cell Biol. Mar; 35(3): 272-6. Review
4.Barnes PJ (1998). Pharmacology of airway smooth muscle. Am J Respir Crit Care Med. Nov; 158(5 Pt 3): S123-32. Review
5.Billington CK, Penn RB (2003). Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res. 4:2. Epub 2003 Mar 14. Review.

延伸閱讀